{
  "id": "d15d954389827185",
  "title": "FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel - L , Confirms 12 - Month Reduction in Back Pain Supports Product Efficacy",
  "description": "20260119T013000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/19/tmt-newswire/globenewswire/fda-acknowledges-effects-on-pain-intensity-favor-rexlemestrocel-l-confirms-12-month-reduction-in-back-pain-supports-product-efficacy/2260887",
  "published_at": "20260119T013000Z",
  "fetched_at": "2026-01-20T00:23:08.181708+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "ai"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/19/tmt-newswire/globenewswire/fda-acknowledges-effects-on-pain-intensity-favor-rexlemestrocel-l-confirms-12-month-reduction-in-back-pain-supports-product-efficacy/2260887",
    "url_mobile": "https://www.manilatimes.net/2026/01/19/tmt-newswire/globenewswire/fda-acknowledges-effects-on-pain-intensity-favor-rexlemestrocel-l-confirms-12-month-reduction-in-back-pain-supports-product-efficacy/2260887/amp",
    "title": "FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel - L , Confirms 12 - Month Reduction in Back Pain Supports Product Efficacy",
    "seendate": "20260119T013000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/19/903895.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}